Millennium Management’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-32,172
| Closed | -$43.1K | – | 4462 |
|
|
2024
Q3 | $43.1K | Sell |
32,172
-66,346
| -67% | -$88.9K | ﹤0.01% | 3935 |
|
|
2024
Q2 | $128K | Sell |
98,518
-49,354
| -33% | -$64.2K | ﹤0.01% | 3669 |
|
|
2024
Q1 | $254K | Sell |
147,872
-985
| -0.7% | -$1.69K | ﹤0.01% | 3570 |
|
|
2023
Q4 | $219K | Buy |
148,857
+29,163
| +24% | +$42.9K | ﹤0.01% | 3533 |
|
|
2023
Q3 | $145K | Sell |
119,694
-254,156
| -68% | -$308K | ﹤0.01% | 3695 |
|
|
2023
Q2 | $542K | Sell |
373,850
-120,691
| -24% | -$175K | ﹤0.01% | 3234 |
|
|
2023
Q1 | $717K | Sell |
494,541
-381,857
| -44% | -$554K | ﹤0.01% | 3253 |
|
|
2022
Q4 | $1.52M | Buy |
876,398
+188,002
| +27% | +$325K | ﹤0.01% | 2882 |
|
|
2022
Q3 | $1.38M | Buy |
688,396
+373,753
| +119% | +$748K | ﹤0.01% | 3128 |
|
|
2022
Q2 | $233K | Buy |
314,643
+253,382
| +414% | +$188K | ﹤0.01% | 4389 |
|
|
2022
Q1 | $533K | Buy |
+61,261
| New | +$533K | ﹤0.01% | 4039 |
|
|
2021
Q2 | – | Sell |
-12,635
| Closed | -$186K | – | 5330 |
|
|
2021
Q1 | $186K | Sell |
12,635
-45,427
| -78% | -$669K | ﹤0.01% | 4176 |
|
|
2020
Q4 | $1.13M | Sell |
58,062
-72,512
| -56% | -$1.41M | ﹤0.01% | 2834 |
|
|
2020
Q3 | $1.46K | Buy |
130,574
+94,581
| +263% | +$1.06K | ﹤0.01% | 2238 |
|
|
2020
Q2 | $487K | Buy |
35,993
+21,938
| +156% | +$297K | ﹤0.01% | 2753 |
|
|
2020
Q1 | $114K | Buy |
14,055
+1,373
| +11% | +$11.1K | ﹤0.01% | 2860 |
|
|
2019
Q4 | $122K | Buy |
+12,682
| New | +$122K | ﹤0.01% | 3268 |
|
|
2018
Q2 | – | Sell |
-11,415
| Closed | -$163K | – | 3720 |
|
|
2018
Q1 | $163K | Buy |
+11,415
| New | +$163K | ﹤0.01% | 3174 |
|